Inhibitory effect of the Cree traditional medicine wiishichimanaanh (Vaccinium vitis-idaea) on advanced glycation endproduct formation: identification of active principles.
Like many aboriginal populations, First Nations communities such as the Cree of Eeyou Istchee are facing continuously increasing rates of diabetes and related complications. Advanced glycation endproducts (AGEs), which readily form and accumulate with sustained hyperglycemia, contribute to the development of diabetic complications and, as such, are considered a potential therapeutic target. In the present study, the inhibition of AGE formation by ethanolic extracts of the Cree medicinal plant Vaccinium vitis-idaea L. was assessed by fluorometric detection of fluorescent AGEs and immunodetection of N(epsilon)-(carboxymethyl)lysine adducts of albumin. Extracts from V. vitis-idaea berries demonstrated a concentration-dependent inhibition of AGE formation in both measures. High performance liquid chromatography mass spectrometry (HPLC/MS) identified nine main phenolic constituents. Four were selected for further testing, of which catechin, quercetin-3-O-galactoside and cyanidin-3-O-glucoside but not para-coumaric acid displayed antiglycation activities. These results demonstrate that the flavonoid components of the berry extract are potent antiglycation agents and provide pharmacological validation for the traditional use of V. vitis-idaea as an antidiabetic remedy.
Beaulieu
Louis-Philippe
LP
Canadian Institute of Health Research Team in Aboriginal Anti-diabetic Medicines, Department of Pharmacology, Université de Montréal, QC, Canada.
Harris
Cory S
CS
Saleem
Ammar
A
Cuerrier
Alain
A
Haddad
Pierre S
PS
Martineau
Louis C
LC
Bennett
Steffany A L
SA
Arnason
John T
JT
D002851:Chromatography, High Pressure Liquid; D005419:Flavonoids / Q000737:chemistry* / Q000302:isolation & purification; D005638:Fruit / Q000737:chemistry; D017127:Glycation End Products, Advanced / Q000737:chemistry*; D008239:Lysine / Q000031:analogs & derivatives; D008519:Medicine, Traditional; D010636:Phenols / Q000737:chemistry* / Q000302:isolation & purification; D010936:Plant Extracts / Q000737:chemistry*; D029801:Vaccinium vitis-idaea / Q000737:chemistry*
D005419:Flavonoids; D017127:Glycation End Products, Advanced; D010636:Phenols; D010936:Plant Extracts; C048496:N(6)-carboxymethyllysine; D008239:Lysine